health pharma news today obesity drugs glp-1 World Leaders | FDA Approves First Oral Pill, Novo Nordisk to Launch in 2026 The FDA's approval of Novo Nordisk's first oral GLP-1 pill What is the pipeline for
Description
Tirzepatide-induced injection site reaction
Traditionally, the medication was used to control blood sugar, making it a preferred treatment for type 2 diabetes
Within the GLP-1 analog, Ala8 is replaced by Gly to resist DPP-4 degradation, and Gly36 is substituted for Arg to avoid a potential T-cell epitope interaction [86]
Moreover, affordability and reimbursement barriers further inhibit widespread adoption globally
Patients on GLP-1 drugs had a 23% lower rate of developing DME one to two years after initiation of treatment compared to control
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
